Afatinib or Bevacizumab in combination with Osimertinib efficiently control tumor development in orthotopic murine models of non-small lung cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

PLoS ONE

Topics

Medicine

Cancer Oncology

Internal Medicine

Pulmonary And Respiratory Medicine

Biotechnology

Show all topics

DOI

10.1371/journal.pone.0304914

License

CC-BY

Other Formats

PDF